Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers

BACKGROUND AND AIM: We evaluated the clinicopathological and prognostic significance of serum p53 (s‐p53‐Abs) and serum NY‐ESO‐1 autoantibodies (s‐NY‐ESO‐1‐Abs) in esophageal squamous cell carcinoma (ESCC), gastric cancer and hepatocellular carcinoma (HCC). PATIENTS AND METHODS: A total of 377 patie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Gastroenterol Surg
Autors principals: Hoshino, Isamu, Nabeya, Yoshihiro, Takiguchi, Nobuhiro, Gunji, Hisashi, Ishige, Fumitaka, Iwatate, Yosuke, Shiratori, Fumiaki, Yajima, Satoshi, Okada, Rei, Shimada, Hideaki
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7240143/
https://ncbi.nlm.nih.gov/pubmed/32490341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12325
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars